Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT01294579
Brief Title: Ofatumumab and Bendamustine Followed by Maintenance Ofatumumab for Rituximab Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL)

First Submitted : February 3, 2011
First Submitted that Met QC Criteria : February 10, 2011
First Posted : February 11, 2011 (Estimate)

Results First Submitted : December 15, 2017
Results First Submitted that Met QC Criteria : August 6, 2018
Results First Posted : August 9, 2018

Last Update Submitted that Met QC Criteria : August 6, 2018
Last Update Posted : August 9, 2018